Navi Mumbai
08045132072
+918209542042

'healthcare provider administration'

Items tagged with 'healthcare provider administration'

68cd26b4d317e049914de2d3 Card 2

product image
Cardiology
INR 49 INR 70

Verified

68cd26b4d317e049914de2d3 Card 2

product image
Respiratory
INR 182 INR 304

Verified

68cd26b4d317e049914de2d3 Card 2

product image
Gastrology
INR 2030 INR 2900

Verified

68cd26b4d317e049914de2d3 Card 2

product image
GYNAECOLOGY

ELIGOLUX 200 is a prescription medication formulated with Elagolix 200 mg, a gonadotropin-releasing hormone (GnRH) receptor antagonist. This innovative drug is primarily used in the management of moderate to severe pain associated with endometriosis, a condition in which tissue similar to the uterine lining grows outside the uterus, causing chronic pelvic pain and menstrual irregularities. ELIGOLUX 200 works by suppressing the production of ovarian hormones, particularly estrogen, which helps reduce endometriosis-related pain and improves quality of life for women experiencing this condition. Manufactured under strict quality standards, ELIGOLUX 200 ensures safety, efficacy, and consistent therapeutic outcomes. Uses ELIGOLUX 200 is indicated for the management of symptoms related to endometriosis, including: Moderate to severe pelvic pain associated with endometriosis. Dysmenorrhea (painful menstrual periods) caused by endometriosis. Non-menstrual pelvic pain and discomfort associated with endometrial lesions. In some cases, it may be used under medical supervision to reduce reliance on surgical interventions for pain management. By targeting the hormonal pathway that contributes to endometriosis, ELIGOLUX 200 helps control symptoms effectively without affecting other body systems significantly. Benefits Taking ELIGOLUX 200 under the supervision of a healthcare professional provides several advantages: Significant Pain Relief: Reduces pelvic and menstrual pain associated with endometriosis. Improved Quality of Life: Allows patients to perform daily activities with reduced discomfort. Non-Surgical Option: Offers an alternative to surgery for managing endometriosis-related pain. Hormonal Regulation: Suppresses estrogen levels temporarily to prevent growth and inflammation of endometrial tissue. Clinically Supported: Elagolix has been studied in multiple clinical trials demonstrating its efficacy and safety in endometriosis management. ELIGOLUX 200 provides targeted symptom management, making it a preferred choice for women seeking relief from chronic endometriosis pain. Dosage ELIGOLUX 200 should be taken strictly according to a doctor’s prescription. Typical dosing guidelines include: Standard Dose: One Elagolix 200 mg tablet once or twice daily, depending on the severity of symptoms and physician recommendation. Administration: Tablets should be swallowed whole with water, with or without food. Treatment Duration: Usually prescribed for 6 months, though your doctor may adjust the duration based on response and side effect profile. Important: Avoid altering the dose or frequency without consulting a healthcare provider, as it may reduce effectiveness or increase the risk of side effects. Side Effects While ELIGOLUX 200 is generally well-tolerated, some patients may experience mild to moderate side effects, such as: Hot flashes or night sweats Headache or dizziness Nausea Decreased bone mineral density with long-term use Mood changes or fatigue Serious side effects are rare but may include severe liver issues or allergic reactions. Regular monitoring, including bone health assessments, may be advised during extended therapy. Precautions and Warning To ensure safe use of ELIGOLUX 200, observe the following precautions: Pregnancy & Breastfeeding: Avoid use during pregnancy. Women of childbearing potential should use effective contraception. Consult your doctor if breastfeeding. Bone Health: Long-term use may reduce bone mineral density; consider calcium and vitamin D supplementation. Medical Conditions: Inform your doctor if you have liver disease, osteoporosis, or other hormonal disorders. Drug Interactions: Avoid combining with other hormonal medications unless approved by a physician. Follow-Up: Regular medical check-ups are recommended to monitor response and side effects. Adhering to these precautions ensures optimal therapeutic benefit while minimizing risks associated with hormone suppression. Conclusion ELIGOLUX 200 – Elagolix Tablets 200 mg is a targeted therapy for managing moderate to severe endometriosis-related pain. By temporarily suppressing ovarian hormone production, it provides effective pain relief, improves daily functioning, and reduces the need for surgical interventions in many cases. Manufactured under strict quality standards by healthcare professionals, ELIGOLUX 200 is a trusted option for women seeking safe, reliable, and clinically supported endometriosis management. Following prescribed dosage, monitoring, and medical guidance ensures maximum benefit with minimal risk, helping patients regain comfort and quality of life.

Verified

68cd26b4d317e049914de2d3 Card 2

product image
GYNAECOLOGY

ELIGOLUX 150 is a prescription medication containing Elagolix, a gonadotropin-releasing hormone (GnRH) receptor antagonist. This medicine is primarily used to manage conditions associated with endometriosis, a painful disorder where tissue similar to the uterine lining grows outside the uterus. Elagolix works by reducing the production of estrogen in the body, which in turn helps decrease endometriosis-related pain, including pelvic discomfort and heavy menstrual bleeding. Manufactured under strict quality standards, ELIGOLUX 150 ensures consistent efficacy and safety for patients seeking reliable relief from endometriosis symptoms. Uses ELIGOLUX 150 is primarily prescribed for: Endometriosis-related pain: Helps manage moderate to severe pelvic pain, dysmenorrhea (painful menstruation), and non-menstrual pelvic pain. Management of heavy menstrual bleeding: Can reduce excessive bleeding associated with endometriosis. Support in infertility treatment: Sometimes used as part of protocols to manage endometriosis prior to fertility procedures. Elagolix provides a targeted approach to reducing estrogen levels, which helps slow the growth of endometriotic tissue and alleviates associated discomfort. Benefits Using ELIGOLUX 150 under medical supervision offers several advantages: Effective Pain Relief: Reduces pelvic and menstrual pain associated with endometriosis. Improved Quality of Life: Helps patients perform daily activities with less discomfort. Targeted Action: Works directly on the GnRH receptors to regulate hormone levels. Short-Term Treatment Option: Provides relief without long-term hormonal therapy for patients who may not tolerate continuous treatment. Clinically Supported: Elagolix has been studied extensively and is approved in multiple countries for endometriosis management. With consistent use as prescribed, ELIGOLUX 150 can help women regain comfort and control over their daily routine. Dosage The dosage of ELIGOLUX 150 should always be determined by a qualified healthcare provider. General guidelines include: Typical Dose: One tablet of Elagolix 150 mg once daily, preferably taken at the same time each day. Administration: Swallow the tablet with water, with or without food. Treatment Duration: Usually prescribed for up to 6 months for moderate doses; higher doses or longer durations should be carefully monitored by a doctor. Important: Do not alter the dose or discontinue therapy without consulting your physician, as this may affect treatment efficacy and symptom control. Side Effects While ELIGOLUX 150 is generally well-tolerated, some patients may experience mild to moderate side effects, such as: Hot flashes or night sweats Headache Nausea Fatigue or dizziness Reduced bone mineral density with long-term use Serious side effects are rare but may include: Severe mood changes or depression Allergic reactions like rashes, itching, or swelling Liver function abnormalities Regular monitoring and follow-up with a healthcare provider are recommended, especially during long-term therapy. Precautions and Warning To ensure safe use of ELIGOLUX 150, observe the following precautions: Pregnancy and Breastfeeding: Should not be used during pregnancy; consult your doctor before breastfeeding. Bone Health: Long-term use may reduce bone density; calcium and vitamin D supplementation may be advised. Medical History: Inform your doctor if you have liver disease, depression, or other hormonal disorders. Drug Interactions: Avoid combining with other hormone therapies or certain medications without medical guidance. Regular Checkups: Periodic monitoring of liver function, bone health, and overall hormone levels is recommended. Conclusion ELIGOLUX 150 – Elagolix Tablets offers a safe and effective option for women suffering from endometriosis-related pain and heavy menstrual bleeding. By regulating estrogen levels through targeted GnRH receptor antagonism, it reduces pelvic discomfort and improves quality of life. With proper medical supervision, adherence to prescribed dosage, and attention to precautions, ELIGOLUX 150 can provide reliable relief and support overall reproductive health. Always consult your healthcare provider before starting therapy to ensure the best outcomes and minimize potential risks.

Verified

68cd26b4d317e049914de2d3 Card 2

product image
Cardiology
INR 29 INR 42

Verified

68cd26b4d317e049914de2d3 Card 2

product image
Orthopedics
INR 219 INR 313

Verified

68cd26b4d317e049914de2d3 Card 2

product image
Neurology
INR 72 INR 102

Verified

Still searching for
healthcare provider administration?